Filing Details

Accession Number:
0001708138-22-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-16 16:18:03
Reporting Period:
2022-02-14
Accepted Time:
2022-02-16 16:18:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-14 10,000 $179.13 68,470 No 4 M Direct
Common Stock Disposition 2022-02-14 6,460 $626.79 62,010 No 4 F Direct
Common Stock Disposition 2022-02-15 99 $622.09 61,911 No 4 S Direct
Common Stock Disposition 2022-02-15 50 $625.90 61,861 No 4 S Direct
Common Stock Disposition 2022-02-15 421 $626.51 61,440 No 4 S Direct
Common Stock Disposition 2022-02-15 630 $627.49 60,810 No 4 S Direct
Common Stock Disposition 2022-02-15 520 $628.62 60,290 No 4 S Direct
Common Stock Disposition 2022-02-15 533 $629.35 59,757 No 4 S Direct
Common Stock Disposition 2022-02-15 434 $630.41 59,323 No 4 S Direct
Common Stock Disposition 2022-02-15 185 $631.67 59,138 No 4 S Direct
Common Stock Disposition 2022-02-15 289 $632.71 58,849 No 4 S Direct
Common Stock Disposition 2022-02-15 220 $633.54 58,629 No 4 S Direct
Common Stock Disposition 2022-02-15 159 $634.43 58,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2022-02-14 10,000 $0.00 10,000 $179.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2022-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,269 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  3. Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  4. Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  5. Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  6. Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  7. Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  8. Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  9. Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  10. Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  11. Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
  12. The stock option award vests in four equal annual installments, commencing one year after the date of grant.